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Introduction: Antimicrobial are among the most utilized drugs where yearly expenditure 
increased is parallel with usage and could lead to antimicrobial resistance (AMR). Drug 
utilization review is the recommended method to provide an insight on the pattern of use, 
determinants of use, quality of use and outcome of use.  
Objectives: The objective of the study is to describe the patterns of use of selected 
antimicrobial prescribing among haematology patients in Ampang Hospital. The specific 
objectives are to examine the prescribing of antimicrobials is in concordance to the current 
guideline, to determine the rational of antimicrobials prescribed by estimating the defined 
daily dose (DDD), to describe the pattern of usage and to identify factors that influence 
pattern of antimicrobial usage.  
Method: This is descriptive retrospective drug utilization study of antimicrobials among 
haematological patient in Ampang Hospital. The study was conducted on haematology 
patients because of their differences in health background, such as immunocompromised, 
compromised state, and others hematologic patient condition. Patient data who were 
antimicrobial user were extracted from electronic system namely e-HIS system. The defined 
daily dose (DDD) was applied in the analysis and the comparison data.  
Results and discussion: A total of 152 patients data were evaluated with the mean age of 46 
years old (SD 16.9). There were 40 antibacterial, 8 antifungal and 2 antiviral agents. The low 
cases of antifungal and antiviral drug used were because it as an adjunct therapy for patients 
with fever neutropenic sepsis, stem cell transplants procedure and common fungal and viral 
infection. Majority of patients received antimicrobial agents within 7 days of treatment. 
Regardless of age category, gender, race, and diagnosis, there is no difference of 
antimicrobial prescribing generally, most of the antimicrobial prescribed adhered to the 
current guideline. Statistically significant association were between diagnosis and prescriber 
category and CNS result with antibacterial only versus a combination of antimicrobial 
(p<0.05). Based on the DDD the most prescribed antimicrobials were cefepime injection 
(222), meropenem injection (96.31) and piperacillin/tazobactam injection (51.39) for the 
antibacterial, fluconazole capsule (53.79) for antifungal and acyclovir tablet (8.74) for 
antiviral drugs. VEN analysis showed that the highest usage for antibacterial, antifungal and 
antiviral were linezolid injection, caspofungin injection and acyclovir tablet respectively.  
Conclusion: The results of this study showed that antimicrobial agents patterns of use at the 
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